TipRanks
Revolution Medicines (DE:42Z)
XETRA:42Z
Germany Market
42Z
Revolution Medicines
RESEARCH TOOLSreports

Revolution Medicines (42Z) Income Statement

16 Followers

Revolution Medicines Income Statement

Last quarter (Q2 2026), Revolution Medicines's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Revolution Medicines's net income was $-644.37M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 11.58M$ 35.38M$ 29.39M
Gross Profit
$ -16.56M$ 0.00$ 11.58M$ 35.38M$ 29.39M
Operating Expenses
$ 1.17B$ 689.52M$ 498.76M$ 293.66M$ 217.40M
Depreciation and Amortization
$ 16.56M$ 11.82M$ 9.31M$ 9.66M$ 7.33M
EBITDA
$ -1.09B$ -589.02M$ -430.28M$ -239.47M$ -179.75M
Operating Income
$ -1.18B$ -689.52M$ -487.19M$ -258.28M$ -188.01M
Other Income/Expenses
$ 51.07M$ 88.68M$ 47.29M$ 9.15M$ 917.00K
Pretax Income
$ -1.13B$ -600.85M$ -439.89M$ -249.13M$ -187.09M
Net Income
$ -1.13B$ -600.09M$ -436.37M$ -248.71M$ -187.09M
Per Share Metrics
Basic EPS
$ -5.95$ -3.58$ -3.86$ -3.08$ -2.47
Diluted EPS
$ -5.95$ -3.58$ -3.86$ -3.08$ -2.47
Weighted Average Shares Outstanding
 190.13M 167.74M 113.15M 80.63M 72.81M
Weighted Average Shares Outstanding (Diluted)
 190.13M 167.74M 113.15M 80.63M 72.81M
Currency in USD

Revolution Medicines Earnings and Revenue History